Helping people with HIV who smoke cigarettes reduce harm
Official title: Trial of a harm reduction strategy for people with HIV who smoke cigarettes
Funded at Albert Einstein College of Medicine · NIH-11078816 · Data updated 2026-11-12
This study is designed to help people with HIV who smoke cigarettes by providing support and medication to help them quit, along with resources for those who may still smoke, all aimed at improving their overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $708,477 |
| NIH project number | 5R01CA275521-03 |
| Project ID | NIH-11078816 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals living with HIV who currently smoke cigarettes.
✕Less likely to help
Patients who do not smoke or are not living with HIV may not benefit from this research.
What this research studies
This research aims to support individuals living with HIV who smoke cigarettes by evaluating a harm reduction strategy. Participants will receive a combination of behavioral support and medication to help them quit smoking, along with additional resources for those who continue to smoke. The study includes an informational video to encourage smoking reduction and offers lung cancer screening and referrals for health management based on individual health metrics. The goal is to improve overall health outcomes for this population.
Why it matters
Potential benefit: If successful, this research could lead to improved health and reduced smoking-related risks for people living with HIV.
How similar studies have gone: Previous research has shown promise in harm reduction strategies for smoking cessation, indicating potential for success in this approach.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Shuter, Jonathan — Albert Einstein College of Medicine
- Study coordinator: Shuter, Jonathan
Related research
Other NIH-funded projects on the same topics.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
Collaborative research network program for advancements in health science
A NIH-funded multi-institution project aims to advance health science through coordinated research efforts over five years for potential patient benefits.
-
Collaborative NIH Initiative to Advance Health
A national team project aims to make progress in a broad health area with potential benefits for patients.
-
A decentralized, post-incarceration program to help people living with or at risk for HIV
A patient-facing program called DEST2nation aims to help people recently released from jail or prison stay on HIV treatment (ART) and prevention (PrEP) by coordinating care, housing, and support services through peers and community organizations.
-
Project-002: a patient-facing look at a multi-institution effort
A concise, patient-friendly overview of a multi-site NIH project that may explore new approaches to health care over several years.
-
Plug-and-play vaccine and antibody blueprints for emerging flu-like viruses
A multi-team NIH grant aims to create adaptable vaccine and antibody blueprints to rapidly respond to new enveloped RNA viruses in three families.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.